发明名称 |
Pharmaceutical formulation. |
摘要 |
<p>The residence time in the human stomach of pharmaceutical, gastric controlled release, solid units can be increased significantly if the units have a density that is much higher than normal. A preferred oral dosage form according to the invention comprises a capsule or other dosage form having a dimension above 2mm and that contains one or more of the said units. The density of each unit is preferably at least 2.5 and usually at least 2.7g/ml and can conveniently be achieved by including at least 50% by weight of a weighting agent such as barium sulphate.</p> |
申请公布号 |
EP0265061(A1) |
申请公布日期 |
1988.04.27 |
申请号 |
EP19870307973 |
申请日期 |
1987.09.09 |
申请人 |
LONDON SCHOOL OF PHARMACY INNOVATIONS LTD |
发明人 |
NEWTON, JOHN MICHAEL;DEVEREUX, JANE ELIZABETH |
分类号 |
A61K9/16;A61K9/22;A61K9/52;A61K9/54;(IPC1-7):A61K9/52 |
主分类号 |
A61K9/16 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|